AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Conditions: Gastric Cancer; Gastroesophageal Junction Cancer; Pancreatic Adenocarcinoma

Interventions: Drug: AZD0901; Drug: 5-Fluorouracil; Drug: Leucovorin; Drug: l-leucovorin; Drug: Irinotecan; Drug: Nanoliposomal Irinotecan; Drug: Gemcitabine

Sponsors: AstraZeneca

**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

January 24, 2024Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments